Abbott Laboratories (ABT)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 6.06 | 6.11 | 7.02 | 6.64 | 5.40 | |
| DSO | days | 60.25 | 59.74 | 51.99 | 54.97 | 67.65 |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.06
= 60.25
Based on the data provided, the days of sales outstanding (DSO) for Abbott Laboratories are not available for the years spanning from December 31, 2020, to December 31, 2024. The lack of specific DSO values makes it challenging to evaluate the efficiency of Abbott Laboratories in collecting accounts receivable and managing its working capital during this period. It would be beneficial to have access to the DSO figures for a more in-depth analysis of the company's receivables management and liquidity position over these years.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Abbott Laboratories
ABT
60.25
CONMED Corporation
CNMD
66.39
Stryker Corporation
SYK
58.70